KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹170 Cr | ₹152 Cr | ₹126 Cr | ₹139 Cr | ₹78 Cr |
What is the latest Total Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹170 Cr |
| Mar2024 | ₹152 Cr |
| Mar2023 | ₹126 Cr |
| Mar2022 | ₹139 Cr |
| Mar2021 | ₹78 Cr |
How is Total Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹170 Cr | 11.63 | |
| Mar2024 | ₹152 Cr | 20.57 | |
| Mar2023 | ₹126 Cr | -9.71 | |
| Mar2022 | ₹139 Cr | 78.16 | |
| Mar2021 | ₹78 Cr | - | |
Compare Total Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,467.9 Cr | 0.2% | 26.2% | 92.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 0.2% |
26.2% |
92.4% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses